澳门网上赌搏平台-澳门官方赌搏网站

方可

发布者:吴志龙发布时间:2022-10-25浏览次数:385

  

方可 讲师 硕士生导师


E-mail: kfang@seu.edu.cn

办公地点:李文正楼北235

 

个人简介

2012年和2018年于中山大学澳门网上赌搏平台学院获得学士和博士学位,2018-2021年于中山大学澳门网上赌搏平台学院进行博士后研究。20219月加入澳门网上赌搏平台澳门网上赌搏平台与技术学院,任讲师,硕士生导师。共发表SCI论文18篇,其中13IF>10。主持国家自然基金青年项目,博士后面上项目等项目,获得江苏省双创博士,澳门网上赌搏平台至善青年学者等荣誉称号。

 

研究方向:转录调控在细胞死亡及疾病中的机制和功能

  1. 转录调控在细胞死亡中的作用机理

       目前,已经十几种不同的细胞死亡途径被鉴定,每一条途径都受不同基因通路的调控,可谓“千亡千面。作为基因表达的起始调控,转录调控在其中扮演什么作用?我们运用多组学分析,分子生物学,细胞生物学,小鼠模型等多种研究手段聚焦不同死亡途径的转录调控研究。

  2. 转录调控在疾病中的功能机制及靶向治疗

       癌基因,抑癌基因等的转录调控异常往往直接介导的癌症产生。我们聚焦于癌症相关基因的转录调控,寻找癌症发生发展的重要调控因子,并以此为基础开发潜在的靶向治疗策略。  

     

代表性论文(*第一作者;#通讯作者):

  1. Zhao XR*, Fang K*, Liu XX*, Yao RH, Wang M, Li FF, Hao SH, He JJ, Wang Y, Fan MH, Huang W, Li YP, Gao C, Lin CQ and Luo ZJ. QSER1 preserves the suppressive status of the pro-apoptotic genes to prevent apoptosis. Cell Death and Differentiation 2022. Nov 12. doi: 10.1038/s41418-022-01085-x.

  2. Huang W, Zeng ZC, Wang WT, Sun YM, Chen YQ, Luo XQ, Fang K#. A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine. Clinical and Translational Medicine 2021, 11(3): e355.

  3. Fang K*, Huang W*, Sun YM, Chen TQ, Zeng ZC, Yang QQ, Pan Q, Han C, Sun LY, Luo XQ, Wang WT, Chen YQ. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression. Genome Biology 2020, 21(1): 269.

  4. Huang W*, Fang K*, Chen TQ, Zeng ZC, Sun YM, Han C, Sun LY, Chen ZH, Yang QQ, Pan Q, Luo XQ, Wang WT, Chen YQ. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression. Journal of HematologyOncology 2019, 12(1): 103.

  5. Fang K*, Han BW*, Chen ZH, Lin KY, Zeng CW, Li XJ, Li JH, Luo XQ, Chen YQ. A distinct set of long non-coding RNAs in childhood MLL-rearranged acute lymphoblastic leukemia: biology and epigenetic target. Human Molecular Genetics 2014, 23(12): 3278-3288.

  6. Fang K, Qian F, Chen YQ. MicroRNAs as regulators in normal hematopoietic and leukemia stem cells: current concepts and clinical implications. Current Molecular Medicine2012 Jun,12(5):536-46.

  7. Huang W, Sun YM, Pan Q, Fang K, Chen XT, Zeng ZC, Chen TQ, Zhu SX, Huang LB, Luo XQ, Wang WT and Chen YQ: The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1. Cell Discovery 2022, 8(1): 117.

  8. Han C, Sun LY, Luo XQ, Pan Q, Sun YM, Zeng ZC, Chen TQ, Huang W, Fang K, Wang WT, Chen YQ. Chromatin-associated orphan snoRNA regulates DNA damage-mediated differentiation via a non-canonical complex. Cell Reports 2022, 38(13): 110421.

  9. Huang W, Chen TQ, Fang K, Zeng ZC, Ye H, Chen YQ. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential. Journal of HematologyOncology 2021, 14(1): 117.

  10. Sun L, Wang W, Han C, Huang W, Sun Y, Fang K, Zeng Z, Yang Q, Pan Q, Chen T, Luo X, Chen Y. The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation. Molecular Cell 2021, 81(21): 4493-4508.

  11. Sun YM, Wang WT, Zeng ZC, Chen TQ, Han C, Pan Q, Huang W, Fang K, Sun LY, Zhou YF, Luo XQ, Luo C, Du X, Chen YQ. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood 2019, 134(18): 1533-1546.

  12. Wang WT, Han C, Sun YM, Chen ZH, Fang K, Huang W, Sun LY, Zeng ZC, Luo XQ, Chen YQ. Activation of the Lysosome-Associated Membrane Protein LAMP5 by DOT1L Serves as a Bodyguard for MLL Fusion Oncoproteins to Evade Degradation in Leukemia.Clinical Cancer Research 2019, 25(9): 2795-2808.

  13. Huang W, Wang WT, Fang K, Chen ZH, Sun YM, Han C, Sun LY, Luo XQ, Chen YQ. MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47. Molecular Cancer 2018, 17(1):

  14. Chen ZH, Wang WT, Huang W, Fang K, Sun YM, Liu SR, Luo XQ, Chen YQ. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway. Cell Death and Differentiation 2017, 24(2): 212-224.

  15. Duan FT, Qian F, Fang K, Lin KY, Wang WT, Chen YQ. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression. Molecular Cancer 2013, 12: 164.